Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Phio Pharmaceuticals Corp. See All Filings	D	2025-11-12 16:35:31 UTC
Amount To Be Raised $25,931,342 Associated Brokers / Dealers H.C. Wainwright & Co, LLC CIK Number 0001533040 Filed Document 0001123292-25-000633 Exclusions or Exemptions 506b Accepted Date 2025-11-12 16:35:31 UTC Type of Offering D Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Phio Pharmaceuticals Corp. See All Filings	D	2025-08-04 12:04:47 UTC
Amount To Be Raised $5,080,826 Associated Brokers / Dealers N/A CIK Number 0001533040 Filed Document 0001123292-25-000336 Exclusions or Exemptions 506b Accepted Date 2025-08-04 12:04:47 UTC Type of Offering D Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Phio Pharmaceuticals Corp. See All Filings	D	2025-01-28 16:16:46 UTC
Amount To Be Raised $3,660,000 Associated Brokers / Dealers H.C. Wainwright & Co, LLC CIK Number 0001533040 Filed Document 0001123292-25-000031 Exclusions or Exemptions 506b Accepted Date 2025-01-28 16:16:46 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Phio Pharmaceuticals Corp. See All Filings	D	2025-01-28 16:12:07 UTC
Amount To Be Raised $5,000,010 Associated Brokers / Dealers H.C. Wainwright & Co, LLC CIK Number 0001533040 Filed Document 0001123292-25-000029 Exclusions or Exemptions 506b Accepted Date 2025-01-28 16:12:07 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Phio Pharmaceuticals Corp. See All Filings	D	2025-01-28 16:06:48 UTC
Amount To Be Raised $6,382,020 Associated Brokers / Dealers H.C. Wainwright & Co, LLC CIK Number 0001533040 Filed Document 0001123292-25-000027 Exclusions or Exemptions 506b Accepted Date 2025-01-28 16:06:48 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Phio Pharmaceuticals Corp. See All Filings	D	2025-01-07 16:06:39 UTC
Amount To Be Raised $480,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001533040 Filed Document 0001123292-25-000005 Exclusions or Exemptions 506b Accepted Date 2025-01-07 16:06:39 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Phio Pharmaceuticals Corp. See All Filings	D	2025-01-03 16:36:18 UTC
Amount To Be Raised $1,314,650 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001533040 Filed Document 0001123292-25-000003 Exclusions or Exemptions 506b Accepted Date 2025-01-03 16:36:18 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Phio Pharmaceuticals Corp. See All Filings	D	2024-07-23 17:43:55 UTC
Amount To Be Raised $6,358,543 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001533040 Filed Document 0001123292-24-000200 Exclusions or Exemptions 506b Accepted Date 2024-07-23 17:43:55 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Phio Pharmaceuticals Corp. See All Filings	D	2023-12-19 13:07:40 UTC
Amount To Be Raised $5,399,124 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001533040 Filed Document 0001123292-23-000208 Exclusions or Exemptions 506b Accepted Date 2023-12-19 13:07:40 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets $No Revenues Type of Security Option To Acquire
Phio Pharmaceuticals Corp. See All Filings	D	2023-06-13 16:40:32 UTC
Amount To Be Raised $10,907,728 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001533040 Filed Document 0001683168-23-004102 Exclusions or Exemptions 506b Accepted Date 2023-06-13 16:40:32 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets $No Revenues Type of Security Equity
Phio Pharmaceuticals Corp. See All Filings	D	2023-05-02 16:15:08 UTC
Amount To Be Raised $4,010,519 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001533040 Filed Document 0001683168-23-002852 Exclusions or Exemptions 506b Accepted Date 2023-05-02 16:15:08 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets $No Revenues Type of Security Option To Acquire
Phio Pharmaceuticals Corp. See All Filings	D	2022-11-23 16:00:37 UTC
Amount To Be Raised $1,750 Associated Brokers / Dealers N/A CIK Number 0001533040 Filed Document 0001567619-22-020839 Exclusions or Exemptions 506b Accepted Date 2022-11-23 16:00:37 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets $No Revenues Type of Security Equity
Phio Pharmaceuticals Corp. See All Filings	D	2021-02-12 17:42:26 UTC
Amount To Be Raised $24,264,137 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001533040 Filed Document 0001683168-21-000554 Exclusions or Exemptions 506b Accepted Date 2021-02-12 17:42:26 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Phio Pharmaceuticals Corp. See All Filings	D	2020-04-14 17:16:30 UTC
Amount To Be Raised $4,375,011 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001533040 Filed Document 0001683168-20-001189 Exclusions or Exemptions 506b Accepted Date 2020-04-14 17:16:30 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Phio Pharmaceuticals Corp. See All Filings	D	2020-02-24 17:27:13 UTC
Amount To Be Raised $1,903,128 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001533040 Filed Document 0001683168-20-000567 Exclusions or Exemptions 506b Accepted Date 2020-02-24 17:27:13 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
RXi Pharmaceuticals Corp See All Filings	D/A	2018-08-17 17:00:31 UTC
Amount To Be Raised $15,261,000 Associated Brokers / Dealers N/A CIK Number 0001533040 Filed Document 0001683168-18-002407 Exclusions or Exemptions 506b Accepted Date 2018-08-17 17:00:31 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
RXi Pharmaceuticals Corp See All Filings	D	2017-08-18 17:17:34 UTC
Amount To Be Raised $15,261,000 Associated Brokers / Dealers N/A CIK Number 0001533040 Filed Document 0001209191-17-049646 Exclusions or Exemptions 506b Accepted Date 2017-08-18 17:17:34 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity